apo-gliclazide mr 30mg tablets, bottle
arrotex pharmaceuticals pty ltd - gliclazide, quantity: 30 mg - tablet, modified release - excipient ingredients: stearic acid; hypromellose; colloidal anhydrous silica - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose. during controlled clinical trials in patients with type ii diabetes, gliclazide mr 30 mg tablets, taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.
zycron mr 30 milligram modified-release tablets
clonmel healthcare ltd - gliclazide - modified-release tablets - 30 milligram - sulfonylureas
vitile mr 30 milligram modified-release tablets
actavis group ptc ehf - gliclazide - modified-release tablets - 30 milligram
vamju 30mg modified-release tablets
mercury pharmaceuticals limited - gliclazide - modified-release tablet - 30mg - sulphonamides, urea derivative - it is indicated in adults for treatment of non-insulin dependent diabetes (type 2) when dietary measures, physical exercise and weight loss alone are not sufficient to control blood glucose.
vamju 60mg modified-release tablets
mercury pharmaceuticals limited - gliclazide - modified-release tablet - 60mg - sulphonamides, urea derivative - it is indicated in adults for treatment of non-insulin dependent diabetes (type 2) when dietary measures, physical exercise and weight loss alone are not sufficient to control blood glucose.
vamju 30mg modified-release tablets
advanz pharma - gliclazide - modified-release tablet - 30mg
vamju 60mg modified-release tablets
advanz pharma - gliclazide - modified-release tablet - 60mg
diadeon mr 60 mg modified release tablets 60 milligram modified-release tablets
les laboratoires servier - gliclazide - modified-release tablets - 60 milligram
none 60 mg modified release tablet modified release tablet
n/a; importer: ambica international corporation; distributor: tgp pharma inc. - gliclazide - modified release tablet - 60 mg modified release tablet
azildor 30mg
actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - gliclazide - modified-release tablet - gliclazide 30 mg - drugs used in diabetes